Literature DB >> 3582478

The effect of propranolol on the rise in plasma ammonia during modest exercise.

P E Hall, S R Smith, M J Kendall.   

Abstract

Changes in plasma ammonia in response to exercise with and without pretreatment with propranolol have been studied. A standardised submaximal treadmill exercise test was used to assess the effects of placebo or propranolol 40 mg, 80 mg, or 160 mg twice daily given in random order for 3 days, the last dose being taken 90 min before exercise. After placebo the mean incremental rise in plasma ammonia in response to exercise was 16 mumol X 1(-1). The corresponding rise after propranolol 40 mg was 56 mumol X 1(-1) (p less than 0.01). All three doses of propranolol produced similar effects on plasma ammonia and exercise heart rates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582478     DOI: 10.1007/bf00542187

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Rapid determination of plasma ammonia using an ion specific electrode.

Authors:  A F Attili; D Autizi; L Capocaccia
Journal:  Biochem Med       Date:  1975-09

2.  Perceived exertion as an indicator of somatic stress.

Authors:  G Borg
Journal:  Scand J Rehabil Med       Date:  1970

3.  Variability of beta-blocker pharmacokinetics in young volunteers.

Authors:  D B Jack; C P Quarterman; R Zaman; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.

Authors:  K Laustiola; A Uusitalo; T Koivula; A Sovijärvi; E Seppälä; T Nikkari; H Vapaatalo
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Micromethod for determining plasma ammonia nitrogen with use of an ion-selective electrode.

Authors:  R J Cooke; R L Jensen
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

6.  Ammonia metabolism during exercise in man.

Authors:  L S Eriksson; S Broberg; O Björkman; J Wahren
Journal:  Clin Physiol       Date:  1985-08

7.  Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension.

Authors:  M Frisk-Holmberg; L Jorfeldt; A Juhlin-Dannfeldt
Journal:  Clin Pharmacol Ther       Date:  1977-06       Impact factor: 6.875

8.  Propranolol increases arterial ammonia in liver cirrhosis.

Authors:  H R van Buuren; P C van der Velden; G Koorevaar; J Silberbusch
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

9.  Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.

Authors:  A A McLeod; J E Brown; C Kuhn; B B Kitchell; F A Sedor; R S Williams; D G Shand
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  Propranolol--a medical treatment for portal hypertension?

Authors:  D Lebrec; O Nouel; M Corbic; J P Benhamou
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

View more
  1 in total

1.  A comparison of the effects of flosequinan, a new vasodilator, and propranolol on sub-maximal exercise in healthy volunteers.

Authors:  H M Lewis; M J Kendall; S R Smith; J R Bratty
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.